It is speculated that although the tumor was initially resistant to TMZ monotherapy because of positive MGMT protein expression, the interferon-beta suppressed MGMT expression by the tumor, thus rendering it sensitive to interferon-TMZ combination treatment. This evidence concerns the gene MGMT and neoplasm.